-transparent.png){kind=logo}
Corynebacterium parvum and Corynebacterium liquefaciens were comparatively examined for their antitumor activity against sarcoma-180 in ddY mice. In the case of ascitic form, significant antitumor effect was observed when C. parvum was administered on days -4 and -2 or day -2. As for solid form, maximal effect was obtained when C. parvum was administered on day 0. On the other hand, C. liquefaciens exhibited maximal antitumor activity against sarcoma-180, both in ascitic and solid forms, when it was administered on days -4 and -2. However, no significant difference in respect to antitumor activity against sarcoma-180 was seen between C. parvum and C. liquefaciens (ascitic form, F1 118 = 0.09, P greater than 0.05; solid form, F1 53 = 0.03, P greater than 0.05).
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
January 1980,
Journal of immunopharmacology,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
January 1978,
Advances in cancer research,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
June 1977,
Tsurumi shigaku. Tsurumi University dental journal,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
June 1979,
Hiroshima journal of medical sciences,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
April 1972,
Gan,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
August 1977,
Gan,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
February 1976,
Journal of the National Cancer Institute,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
June 1976,
Gan,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
January 1977,
Annales d'immunologie,
H Ideda, and
S Yamagata, and
T Toge, and
T Hattori
March 1978,
Journal of the National Cancer Institute,
